Literature DB >> 16763962

A new detection method for ATRX gene mutations using a mismatch-specific endonuclease.

Takahito Wada1, Yoshimitsu Fukushima, Shinji Saitoh.   

Abstract

X-linked alpha-thalassemia/mental retardation syndrome (ATR-X, OMIM 301040) is a syndromic form of X-linked mental retardation (XLMR). It is caused by a mutation in the ATRX gene, which is also involved in other syndromic forms of XLMR as well as in non-syndromic XLMR, both in males and in females. To analyze the full range of disease-causing mutations for genetic counseling and to establish phenotype-genotype correlations, we have established a new screening method for mutations in the ATRX gene, which uses mismatch-specific endonuclease. We applied this method to confirm 13 known mutations in our patients, some of which have been difficult to be demonstrated by conventional denaturing high-performance liquid chromatography. Furthermore, we found four additional mutations in four ATR-X patients whose clinical diagnosis had not been confirmed at the molecular level. In this method, experimental conditions do not need to be altered depending on mutation sites, and it should be the alternative method for mutation screening. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16763962     DOI: 10.1002/ajmg.a.31310

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  3 in total

1.  Screening for mutations in kidney-related genes using SURVEYOR nuclease for cleavage at heteroduplex mismatches.

Authors:  Konstantinos Voskarides; Constantinos Deltas
Journal:  J Mol Diagn       Date:  2009-06-12       Impact factor: 5.568

2.  A Sensitive PCR-Based Method for Somatic Mutations Enrichment and Screening.

Authors:  Yaming Xiong; Hailing Tang
Journal:  Cancer Manag Res       Date:  2021-10-27       Impact factor: 3.989

3.  Recombinant nucleases CEL I from celery and SP I from spinach for mutation detection.

Authors:  Maxim Pimkin; Elena Caretti; Adrian Canutescu; Jeffrey B Yeung; Heather Cohn; Yibai Chen; Catherine Oleykowski; Alfonso Bellacosa; Anthony T Yeung
Journal:  BMC Biotechnol       Date:  2007-06-01       Impact factor: 2.563

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.